Skip to Main Content
Contribute Try STAT+ Today

This spring, the National Institutes of Health announced a dramatic change to the way it would support biomedical research in the United States. NIH Director Francis Collins offered a bold new approach called the Grant Support Index (GSI) that would bolster funding to early-career researchers and limit the number of major NIH research projects that any individual could oversee to three. This approach to funding was proposed in part to grow a larger research community, and in part to ensure that individual researchers were able to responsibly oversee their funded work.

But then Collins talked to advisors at the NIH and changed his mind. Within a month, the GSI was out, and the Next Generation Researchers Initiative — essentially the current flawed system — was in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.